Slamon DJ - Search Results

1

Identification of common predictive markers of in vitro response to the Mek inhibitor selumetinib (AZD6244; ARRY-142886) in human breast cancer and non-small cell lung cancer cell lines.

Garon EB, Finn RS, Hosmer W, Dering J, Ginther C, Adhami S, Kamranpour N, Pitts S, Desai A, Elashoff D, French T, Smith P, Slamon DJ. Garon EB, et al. Among authors: slamon dj. Mol Cancer Ther. 2010 Jul;9(7):1985-94. doi: 10.1158/1535-7163.MCT-10-0037. Epub 2010 Jun 29. Mol Cancer Ther. 2010. PMID: 20587667 Free PMC article.

2

Studies of the HER-2/neu proto-oncogene in human breast cancer.

Slamon DJ. Slamon DJ. Cancer Invest. 1990;8(2):253. doi: 10.3109/07357909009017573. Cancer Invest. 1990. PMID: 1976032 No abstract available.

3

Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group.

Levin WJ, Press MF, Gaynor RB, Sukhatme VP, Boone TC, Reissmann PT, Figlin RA, Holmes EC, Souza LM, Slamon DJ. Levin WJ, et al. Among authors: slamon dj. Oncogene. 1995 Oct 5;11(7):1261-9. Oncogene. 1995. PMID: 7478546

4

Tumor suppressor and immediate early transcription factor genes in non-small cell lung cancer.

Levin WJ, Casey G, Ramos JC, Arboleda MJ, Reissmann PT, Slamon DJ. Levin WJ, et al. Among authors: slamon dj. Chest. 1994 Dec;106(6 Suppl):372S-376S. Chest. 1994. PMID: 7988267 Review.

5

Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group.

Reissmann PT, Koga H, Takahashi R, Figlin RA, Holmes EC, Piantadosi S, Cordon-Cardo C, Slamon DJ. Reissmann PT, et al. Among authors: slamon dj. Oncogene. 1993 Jul;8(7):1913-9. Oncogene. 1993. PMID: 8390038

6

The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells.

Pegram MD, Finn RS, Arzoo K, Beryt M, Pietras RJ, Slamon DJ. Pegram MD, et al. Among authors: slamon dj. Oncogene. 1997 Jul 31;15(5):537-47. doi: 10.1038/sj.onc.1201222. Oncogene. 1997. PMID: 9247307

7

Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.

Pietras RJ, Pegram MD, Finn RS, Maneval DA, Slamon DJ. Pietras RJ, et al. Among authors: slamon dj. Oncogene. 1998 Oct 29;17(17):2235-49. doi: 10.1038/sj.onc.1202132. Oncogene. 1998. PMID: 9811454

8

Identification of differentially expressed genes associated with HER-2/neu overexpression in human breast cancer cells.

Oh JJ, Grosshans DR, Wong SG, Slamon DJ. Oh JJ, et al. Among authors: slamon dj. Nucleic Acids Res. 1999 Oct 15;27(20):4008-17. doi: 10.1093/nar/27.20.4008. Nucleic Acids Res. 1999. PMID: 10497265 Free PMC article.

9

Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells.

Aguilar Z, Akita RW, Finn RS, Ramos BL, Pegram MD, Kabbinavar FF, Pietras RJ, Pisacane P, Sliwkowski MX, Slamon DJ. Aguilar Z, et al. Among authors: slamon dj. Oncogene. 1999 Oct 28;18(44):6050-62. doi: 10.1038/sj.onc.1202993. Oncogene. 1999. PMID: 10557094

10

A candidate tumor suppressor gene, H37, from the human lung cancer tumor suppressor locus 3p21.3.

Oh JJ, West AR, Fishbein MC, Slamon DJ. Oh JJ, et al. Among authors: slamon dj. Cancer Res. 2002 Jun 1;62(11):3207-13. Cancer Res. 2002. PMID: 12036935

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

321 results

Search Page

Filters